Your browser doesn't support javascript.
loading
Endothelial-to-mesenchymal transition compromises vascular integrity to induce Myc-mediated metabolic reprogramming in kidney fibrosis.
Lovisa, Sara; Fletcher-Sananikone, Eliot; Sugimoto, Hikaru; Hensel, Janine; Lahiri, Sharmistha; Hertig, Alexandre; Taduri, Gangadhar; Lawson, Erica; Dewar, Rajan; Revuelta, Ignacio; Kato, Noritoshi; Wu, Chang-Jiun; Bassett, Roland L; Putluri, Nagireddy; Zeisberg, Michael; Zeisberg, Elisabeth M; LeBleu, Valerie S; Kalluri, Raghu.
Afiliación
  • Lovisa S; Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
  • Fletcher-Sananikone E; Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
  • Sugimoto H; Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
  • Hensel J; Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
  • Lahiri S; Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
  • Hertig A; Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
  • Taduri G; Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
  • Lawson E; Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
  • Dewar R; Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
  • Revuelta I; Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
  • Kato N; Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
  • Wu CJ; Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
  • Bassett RL; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
  • Putluri N; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
  • Zeisberg M; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
  • Zeisberg EM; Department of Nephrology and Rheumatology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075 Göttingen, Germany.
  • LeBleu VS; Department of Cardiology and Pneumology, University Medical Center Göttingen, German Center for Cardiovascular Research (DZHK), Partner Site, Göttingen 37075, Germany.
  • Kalluri R; Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
Sci Signal ; 13(635)2020 06 09.
Article en En | MEDLINE | ID: mdl-32518142

Texto completo: 1 Colección: 01-internacional Asunto principal: Endotelio Vascular / Proteínas Proto-Oncogénicas c-myc / Reprogramación Celular / Enfermedades Renales / Túbulos Renales Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Sci Signal Asunto de la revista: CIENCIA / FISIOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Asunto principal: Endotelio Vascular / Proteínas Proto-Oncogénicas c-myc / Reprogramación Celular / Enfermedades Renales / Túbulos Renales Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Sci Signal Asunto de la revista: CIENCIA / FISIOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos